-
Signature
-
/s/ Erin Guldiken, attorney-in-fact for Mark Zuckerberg
-
Stock symbol
-
META
-
Transactions as of
-
Oct 14, 2024
-
Transactions value $
-
-$50,400
-
Form type
-
4
-
Date filed
-
10/16/2024, 06:21 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
META |
Class A Common Stock |
Sale |
-$50.4K |
-84 |
-0.02% |
$600.00 |
518K |
Oct 14, 2024 |
By Chan Zuckerberg Initiative Foundation |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
holding |
META |
Class B Common Stock |
|
|
|
|
|
244M |
Oct 14, 2024 |
Class A Common Stock |
244M |
|
By CZI Holdings, LLC |
F3, F4 |
holding |
META |
Class B Common Stock |
|
|
|
|
|
3.39M |
Oct 14, 2024 |
Class A Common Stock |
3.39M |
|
By Mark Zuckerberg, Trustee Of The Mark Zuckerberg Trust Dated July 7, 2006 |
F3, F5 |
holding |
META |
Class B Common Stock |
|
|
|
|
|
34.3M |
Oct 14, 2024 |
Class A Common Stock |
34.3M |
|
By Chan Zuckerberg Holdings, LLC |
F3, F6 |
holding |
META |
Class B Common Stock |
|
|
|
|
|
12M |
Oct 14, 2024 |
Class A Common Stock |
12M |
|
By CZI Holdings I, LLC |
F3, F7 |
holding |
META |
Class B Common Stock |
|
|
|
|
|
50M |
Oct 14, 2024 |
Class A Common Stock |
50M |
|
By Chan Zuckerberg Holdings II, LLC |
F3, F8 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: